aid: intervenn name: InterVenn description: 'InterVenn Biosciences is a digital-biology company applying artificial intelligence and mass spectrometry to glycoproteomics, the large-scale study of glycosylated proteins, to discover novel biomarkers for precision medicine. Its proprietary platform integrates liquid chromatography and tandem mass spectrometry (LC-MS) with AI-driven analysis (including the OpenPIP software) to identify and quantify glycopeptides and glycan structures across complex diseases such as cancer. Surfaced as a portfolio company of amplify-partners and softbank-vision-fund and added to the API Evangelist network. InterVenn publishes no public developer API, portal, or specifications as of this enrichment pass; this profile carries company identity and domain-security posture only.' url: https://raw.githubusercontent.com/api-evangelist/intervenn/refs/heads/main/apis.yml x-type: company x-source: vc-portfolio x-backed-by: - amplify-partners - softbank-vision-fund x-tier: stub x-tier-reason: portfolio-lead accessModel: pricing: unknown onboarding: unknown trial: false try_now: false public: false label: Unknown confidence: low source: [] generated: '2026-07-22' method: derived specificationVersion: '0.20' created: '2026-07-17' modified: '2026-07-19' image: https://intervenn.com/images/intervenn-favicon1.jpg tags: - Company - Digital Biology - Glycoproteomics - Proteomics - Mass Spectrometry - Precision Medicine - Biomarkers - Artificial Intelligence - Life Sciences apis: [] maintainers: - FN: Kin Lane email: kin@apievangelist.com - FN: APIs.json email: info@apis.io common: - type: Website url: https://intervenn.com - type: PrivacyPolicy url: https://intervenn.com/privacy-policy/ - type: Support url: https://intervenn.com/contact/ - type: Blog url: https://intervenn.com/news-and-events/ - type: DomainSecurity url: security/intervenn-domain-security.yml x-enrichment: date: '2026-07-19' status: backfilled pass: local-v1 note: backfilled from .gitignore signal + verified work evidence